Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 21, 2024; 30(11): 1533-1544
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1533
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1533
Figure 2 The 1-, 2-, and 3-year follow-up survival curves of the two groups.
A: 1-year follow-up survival curves; B: 2-year follow-up survival curves for the two groups; C: 3-year follow-up survival curves for the two groups.
- Citation: Yang LM, Wang HJ, Li SL, Gan GH, Deng WW, Chang YS, Zhang LF. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors. World J Gastroenterol 2024; 30(11): 1533-1544
- URL: https://www.wjgnet.com/1007-9327/full/v30/i11/1533.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i11.1533